Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.66B |
| 2 |
ORIG
Ocean Rig UDW Inc. Class A Common Shares
ORIG
|
+$1.55B |
| 3 |
RTX Corp
RTX
|
+$664M |
| 4 |
NXP Semiconductors
NXPI
|
+$606M |
| 5 |
Walt Disney
DIS
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$1.46B |
| 2 |
KKR & Co
KKR
|
+$602M |
| 3 |
Meta Platforms (Facebook)
META
|
+$594M |
| 4 |
Mastercard
MA
|
+$560M |
| 5 |
Visa
V
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.15% |
| 2 | Technology | 10.69% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5126
Arrowhead Research
ARWR
$7.9B
| $263K | ﹤0.01% |
60,762
-170,570
| -74% | -$406K |
2013 Q3
16 quarters
|
|
5127
ProShares UltraShort Dow 30
DXD
$44.8M
| $263K | ﹤0.01% |
1,226
+180
| +17% | +$40.5K |
2013 Q3
16 quarters
|
|
5128
Mammoth Energy Services
TUSK
$130M
| $261K | ﹤0.01% |
15,524
-10,940
| -41% | -$160K |
2016 Q4
3 quarters
|
|
|
APF
5129
DELISTED
Morgan Stanley Asia Pacific Fund
APF
| $261K | ﹤0.01% |
15,114
+616
| +4% | +$10.5K |
2013 Q2
17 quarters
|
|
5130
Hennessy Advisors
HNNA
$81M
| $260K | ﹤0.01% |
16,815
+72
| +0.4% | +$1.11K |
2014 Q2
13 quarters
|
|
5131
Arcturus Therapeutics
ARCT
$294M
| $259K | ﹤0.01% |
36,556
+4,809
| +15% | +$36.2K |
2013 Q4
15 quarters
|
|
5132
Camtek
CAMT
$6.04B
| $259K | ﹤0.01% |
50,694
+3,058
| +6% | +$15.1K |
2016 Q4
3 quarters
|
|
5133
J. Jill
JILL
$365M
| $259K | ﹤0.01% |
5,658
+2,260
| +67% | +$107K |
2017 Q1
2 quarters
|
|
|
FCSC
5134
DELISTED
Fibrocell Science Inc.
FCSC
| $259K | ﹤0.01% |
16,880
+9,534
| +130% | +$154K |
2013 Q4
15 quarters
|
|
|
PYN
5135
DELISTED
PIMCO New York Municipal Income Fund III
PYN
| $258K | ﹤0.01% |
25,855
+132
| +0.5% | +$1.31K |
2013 Q2
17 quarters
|
|
|
LLEX
5136
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
| $258K | ﹤0.01% |
57,778
+18,152
| +46% | +$75.6K |
2017 Q2
1 quarter
|
|
5137
RBB Bancorp
RBB
$436M
| $256K | ﹤0.01% |
+11,197
| New | +$252K |
2017 Q3
0 quarters
|
|
5138
Cibus
CBUS
$101M
| $255K | ﹤0.01% |
+208
| New | +$177K |
2017 Q3
0 quarters
|
|
5139
Madrigal Pharmaceuticals
MDGL
$10.4B
| $255K | ﹤0.01% |
5,646
+1,718
| +44% | +$32.2K |
2013 Q2
17 quarters
|
|
5140
Universal Logistics Holdings
ULH
$430M
| $255K | ﹤0.01% |
12,477
+4,600
| +58% | +$73.6K |
2013 Q2
17 quarters
|
|
|
QHC
5141
DELISTED
Quorum Health Corporation
QHC
| $255K | ﹤0.01% |
49,532
-78,113
| -61% | -$318K |
2016 Q2
5 quarters
|
|
|
ADAP
5142
DELISTED
Adaptimmune Therapeutics
ADAP
| $254K | ﹤0.01% |
31,124
+21,753
| +232% | +$136K |
2017 Q1
2 quarters
|
|
5143
EPR Properties 5.75% Series C Preferred Shares
EPR.PRC
$132M
| $254K | ﹤0.01% |
9,150
| – | – |
2015 Q4
7 quarters
|
|
5144
iShares Core International Aggregate Bond Fund
IAGG
$12.5B
| $254K | ﹤0.01% |
4,914
-702
| -13% | -$36.4K |
2017 Q1
2 quarters
|
|
5145
Uranium Energy
UEC
$3.92B
| $253K | ﹤0.01% |
183,365
+49,553
| +37% | +$72.3K |
2013 Q2
17 quarters
|
|
5146
Tiptree Inc
TIPT
$613M
| $252K | ﹤0.01% |
40,192
+16,443
| +69% | +$107K |
2015 Q2
9 quarters
|
|
5147
Flaherty & Crumrine Total Return Fund
FLC
$163M
| $251K | ﹤0.01% |
11,700
-199
| -2% | -$4.31K |
2013 Q2
17 quarters
|
|
5148
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $250K | ﹤0.01% |
10,062
+8,244
| +453% | +$152K |
2017 Q2
1 quarter
|
|
|
WBII
5149
DELISTED
WBI BullBear Global Income ETF
WBII
| $250K | ﹤0.01% |
9,825
+8,726
| +794% | +$222K |
2016 Q2
5 quarters
|
|
|
MUH
5150
DELISTED
Blackrock Muniholdings Fund II, Inc.
MUH
| $250K | ﹤0.01% |
15,966
+594
| +4% | +$9.48K |
2013 Q3
16 quarters
|
|
Similar funds
Morgan Stanley's Q3 2017 Portfolio in Review
As of Q3 2017, Morgan Stanley held 6,889 positions worth $334B, up 0.86% from $331B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q3 2017 filing shows 195 new, 3,466 increased, 2,508 reduced and 247 closed positions. Its largest new stake was JBG SMITH: 4,306,383 shares worth $147M. The largest sale was Reynolds American Inc, an estimated $1.46B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2017 buy was JBG SMITH: 4,306,383 shares worth $147M.
- Morgan Stanley added most to iShares MSCI Emerging Markets ETF in Q3 2017, an estimated $1.66B increase.
- Morgan Stanley's biggest Q3 2017 reduction was KKR & Co, cutting an estimated $602M.
- Morgan Stanley fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.46B.
- Morgan Stanley's ten largest holdings make up 12% of its $334B portfolio in Q3 2017.
- Morgan Stanley opened 195 new positions and closed 247 in Q3 2017.
- Morgan Stanley's portfolio value rose 0.86% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.